We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WW:NASDAQWW International, Inc. Analysis

Data as of 2026-08-31 - not real-time

$15.92

Latest Price

9/10Risk

Risk Level: High

Executive Summary

WW International, Inc. trades at $15.92, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has gained 7.1% over the past 30 days. Relative strength is 52.1 — neutral — and the MACD signal is bullish. The recent range runs from support at $13.06 up to resistance at $19.10.
Valuation screens as undervalued: a P/E of 1.5 sits below the sector average of 30.4. Sell-side targets cluster 78.0% above the current quote. Revenue is contracting at 14.2% on a -15.2% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 92.5%, a beta of 2.39 and a maximum drawdown of 73.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.

Top Market Events

Yahoo Finance25dWW International Inc WW Q2 2026 Earnings Call Highlights: Clinical Growth and Debt .Yahoo Finance25dWW International Q2 Earnings Call HighlightsThe above button links to Coinbase.Seeking Alpha25dWW International, Inc. WW Q2 2026 Earnings Call TranscriptPlease note this event is being recorded. I...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 18.71
  • MACD momentum is positive
  • 30-day price change of +7.1%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 1.5 versus sector average of 30.4
  • Trading below the 200-day average of 18.71
  • Analyst targets imply +78.0% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 1.5 versus sector average of 30.4
  • Negative profit margin of -15.2%
  • Analyst targets imply +78.0% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-14.20%
Profit Margin-15.22%
P/E Ratio1.5
ROE-30.71%
ROA-0.45%
Debt/Equity152.99
P/B Ratio0.5
Op. Cash Flow$-15257000
Free Cash Flow$88.8M
Industry P/E30.4

Technical Analysis

TrendNeutral
RSI52.1
Support$13.06
Resistance$19.10
MA 20$15.65
MA 50$15.47
MA 200$18.71
MACDBullish
VolumeDecreasing
Fear & Greed Index94.41

Valuation

Fair Value$81.46
Target Price$28.33
Upside/Downside77.97%
GradeUndervalued
TypeValue

Risk Assessment

Beta2.39
Volatility92.49%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.